Industry Satellite Symposia Sessions

Non-Metastatic NSCLC And Other Thoracic Malignancies

← Back to the Areas of Interest  

INVITATION

Pfizer Oncology - Is it time to raise the bar for ALK+ NSCLC patients?

View the full invitation

INVITATION

Ipsen - Disrupting the landscape: the Plus One in RCC and NSCLC

View the full invitation